Shinji Kageyama

Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients

Yoshihiro Matsumoto, Yasuo Mori, Shinji Kageyama et al. · Journal of the American College of Cardiology · 2013 · 220 citations

Thrombosis, Hemodialysis, Hemodialysis Patients +11

HAZARDS OF LAPAROSCOPIC ADRENALECTOMY IN PATIENTS WITH ADRENAL MALIGNANCY

Kazuo Suzuki, Tomomi Ushiyama, Soichi Mugiya et al. · The Journal of Urology · 1997 · 78 citations

Laparoscopy, Surgical Oncology, Urology +13

Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study

Minako Wakasugi, Junichiro James Kazama, Akihide Tokumoto et al. · Clinical and Experimental Nephrology · 2013 · 63 citations

Thrombosis, Hemodialysis, Japanese Hemodialysis Patients +15

Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Subanalysis of the J‐RHYTHM Registry

Eitaro Kodani, Hirotsugu Atarashi, Hiroshi Inoue et al. · Journal of the American Heart Association · 2016 · 57 citations · Full text

Long-Term Low-Dose Spironolactone Therapy Is Safe in Oligoanuric Hemodialysis Patients

Yoshihiro Matsumoto, Shinji Kageyama, Toru Yakushigawa et al. · Cardiology · 2009 · 48 citations

Hemodialysis, Urology, Heart Failure +14